Oncolytics Biotech, Inc.

10:50 AM EST - Oncolytics Biotech, Inc. : Announced that Dr. Andres Gutierrez, Oncolytics' Chief Medical Officer, will facilitate a roundtable discussion at hubXchange's inaugural US Immuno-Oncology Strategy Meeting. The "Combination Therapies: Next Generation I-O Combinations for Cancer" roundtable discussion will occur at 9:00 am ET on March 14 in Philadelphia. Oncolytics Biotech, Inc. shares T.ONC are trading down $0.02 at $0.77.